CANNABIS-BASED THERAPEUTIC PRODUCT FOR TREATMENT OF SLEEP DISORDERS
A cannabis-based therapeutic product for treatment of sleep disorders produced (a) harvesting flowers and leaves from a plurality of cannabis plants from a plurality of cannabis strains each expressing a different active cannabis compound profile; (b) individually extracting cannabis oil from the harvested flowers and leaves of each of the cannabis strains; (c) concentrating the extracted cannabis oils by at least evaporating extraneous material; and (d) combining specific amounts of the concentrated oils from one or more cannabis strains to produce a mixture possessing a specific active cannabis compound profile.
1 . A method of preparing a cannabis-based therapeutic product for the treatment of sleep disorders, the method comprising the steps of:
(a) harvesting flowers and leaves from a plurality of cannabis plants from a plurality of cannabis strains each expressing a different active cannabis compound profile using shears;
(b) individually extracting cannabis oil from the harvested flowers and leaves of each of the cannabis strains;
(c) concentrating the extracted cannabis oils by at least evaporating extraneous material; and
(d) combining specific amounts of the concentrated oils from one or more cannabis strains to produce a mixture possessing a specific active cannabis compound profile comprising at least 5% by weight purified cannabinol using a mixing device, wherein the one or more cannabis strains expresses known concentrations of a plurality of active cannabis compounds, the known concentrations being determined using an extract from each cultivar and expressed as a ratio of weight-of-compound per weight-of-extract.
2 . The method of claim 1 , further comprising the step of enriching the product with a formulation comprising at least 1% by weight purified β-myrcene, prior to processing into a final product.
3 . The method of claim 1 , further comprising the step of combining medium-chain triglycerides oils infused with cannabis-based compounds to the concentrated extracted oils, prior to processing into a final product.
4 . The method of claim 1 , wherein the combined formulation is made into pill form.
5 . The method of claim 1 , wherein the combined formulation is made into spray form.
6 . The method of claim 1 , wherein the combined formulation is used to treat plant matter to use in a smokable form.
7 . The method of claim 1 , further comprising cannabis compounds chosen from a set comprising myrcene, a pinene, ocimene, terpineol, beta-caryophyllene, linalool, limonene, terpinolene, valencene, geraniol, phellandrene, carene, terpinene, fenchol, borneol, bisabolol, phytol, camphene, sabinene, camphor, isoborneol, menthol, cedrene, nerolidol, guaiol, isopulegol, geranyl, cymene, and eucalyptol.
8 . A cannabis-based treatment product for sleep disorders produced according to the method of claim 1 .
9 . A cannabis-based treatment product for sleep disorders produced according to the method of claim 2 .
10 . A cannabis-based treatment product for sleep disorders produced according to the method of claim 3 .
11 . A cannabis-based treatment product for sleep disorders produced according to the method of claim 4 .
12 . A cannabis-based treatment product for sleep disorders produced according to the method of claim 5 .
13 . A cannabis-based treatment product for sleep disorders produced according to the method of claim 6 .
14 . A cannabis-based treatment product for sleep disorders produced according to the method of claim 7 .